Krishna Institute of Medical Sciences Results Earnings Call for Q4FY23
Conference Call with Krishna Institute of Medical Sciences Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.19-05-2023
19-05-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Compliance Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
With reference to the captioned subject matter, please find enclosed herewith the Related Parties Transactions of the Company for the Half Year ended March 31, 2023.18-05-2023
Q4FY23 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Healthcare Facilities company Krishna Institute of Medical Sciences announced Q4FY23 results: Consolidated Q4FY23: Revenue from operations grew by 54.7% YoY basis and 2.4% on QoQ basis to Rs 5,759.2 million EBITDA (Pre-INDAS and Other Income) grew by 38.8% on a YoY basis and 8.3% on a QoQ basis to Rs 1,563.3 million EBITDA Margin stands at 27.1% which has improved by 1.4% over the previous quarter; led by operational efficiency PAT grew by 18.4% on a YoY basis and 20.6% on a QoQ basis to Rs 986 million EPS grew by 15.6% on a YoY basis and 22.8% on a QoQ basis to Rs 11.7 Commenting on the performance, Dr. B. Bhaskara Rao, Chairman & Managing Director said: “The last quarter of FY23 saw us deliver our best-ever Quarterly numbers It is a testimony to the continued trust of patients in KIMS’s quality of service, and clinical excellence, and delivering the same with affordability. We continue to focus on identifying experienced clinical talents across specialties and geographies and adding new therapies which will help us drive growth in the coming quarters Our digital automation project to deliver an even better patient experience is progressing at a brisk pace. I am confident we will keep the momentum going in FY24 to deliver patient satisfaction and financial growth together.” Result PDF18-05-2023
Krishna Institute of Medical Sciences Ltd - 543308 - The 21St Annual General Meeting Of The Company Will Be Held On Wednesday, 30Th August 2023.
The 21st Annual General Meeting of the Company will be held on Wednesday, 30th August 2023.18-05-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the Investor Presentation on Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended 31st March 2023.18-05-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the above-stated subject, please find enclosed herewith the Press Release on the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended 31st March 2023.18-05-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Approval Of Audited (Standalone & Consolidated) Financial Results For The Quarter And Year Ended 31St March 2023
Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have approved the Audited Standalone and Consolidated Financial Results of the Company along with the Auditor's Report for the Quarter and Year ended 31st March 2023 issued by M/s. S.R. Batliboi & Associates LLP, the Statutory Auditors of the Company which are enclosed to this letter.18-05-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Outcome Of Board Meeting Held On 18Th May 2023 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
1. Approval of Audited standalone & Consolidated financial results of the Company for the quarter and year ended 31st March 2023, along with the Audit Report on the Standalone & Consolidated Financial Statements. 2. Resignation of CFO18-05-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation about conference call for analysts and investors17-05-2023